Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.7 |
mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.034 | 0.7 |
mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |